Dyadic’s C1 Platform Selected by the Vaccine and Immunotherapy Center (“VIC”) at Massachusetts General Hospital as Part of VIC’s $5.88 Million Award by U.S. DoD to Develop a Self-Assembling Vaccine (SAV) Platform for Rapid Production of Prophylactic Vaccines for Infectious Diseases
October 05, 2023 08:30 ET
|
Dyadic International, Inc.
JUPITER, Fla., Oct. 05, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building...
Dyadic Receives U.S. Patent for Manufacturing Seasonal and Pandemic Influenza Vaccines from its Proprietary C1 Protein Production Platform
April 18, 2023 08:30 ET
|
Dyadic International, Inc.
JUPITER, Fla., April 18, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building...
AMEDICA ANNOUNCES FILING OF KEY PATENT APPLICATION RELATING TO THE ANTI-VIRAL EFFECT OF ITS SILICON NITRIDE
September 10, 2018 09:00 ET
|
Amedica Corporation
SALT LAKE CITY, Sept. 10, 2018 (GLOBE NEWSWIRE) -- Amedica Corporation (NASDAQ: AMDA), a company that develops and commercializes silicon nitride for biomedical applications, today announced the...
VaxInnate Initiates Phase 1b/2 Clinical Trial of Quadrivalent Seasonal Influenza Vaccine Candidate, VAX2012Q, in Elderly
December 08, 2014 08:00 ET
|
VaxInnate Corporation
Cranbury, NJ, Dec. 8, 2014 (GLOBE NEWSWIRE) -- VaxInnate Corporation, a biotechnology firm pioneering a
breakthrough vaccine technology platform, today announced the
initiation of a double-blind,...
A Clinical Update on the Search for a Universal Flu Vaccine: Presentation in Washington, DC on January 30, 2014 in Conjunction With the American Society for Microbiology (ASM) Biodefense Conference
January 28, 2014 08:30 ET
|
AIM ImmunoTech Inc.
PHILADELPHIA, Jan. 28, 2014 (GLOBE NEWSWIRE) -- Hemispherx Biopharma (NYSE MKT:HEB) announced today that the ASM Biodefense Meeting is scheduled for January 27-29, 2014 at the Washington Marriott...
Centers for Disease Control Urges Preparation for an Active Seasonal Flu Season
December 16, 2013 08:30 ET
|
Hemispherx Biopharma, Inc.
PHILADELPHIA, Dec. 16, 2013 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE MKT:HEB) (the "Company" or "Hemispherx") announced that the company will accelerate its experimental program for a new...
Real-Life Contagion Stories: New APHL Book Reveals Heroism of H1N1 Pandemic Response and Recommends Key Measures for Continued Public Safety
September 08, 2011 15:12 ET
|
Association of Public Health Laboratories
SILVER SPRING, MD--(Marketwire - Sep 8, 2011) - The Association of Public Health Laboratories (APHL) today released Lessons from a Virus: Public Health Laboratories Respond to the H1N1 Pandemic....
Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on CEL-SCI Corp.
January 25, 2010 08:30 ET
|
Crystal Research Associates, LLC
NEW YORK, NY--(Marketwire - January 25, 2010) - Crystal Research Associates, LLC announced
today that it has issued an Executive Informational Overview® (EIO®) on
CEL-SCI Corp. (NYSE Amex:...
New York City Department of Education Leverages CyberShift's Workforce Management System for Rapid Implementation of H1N1 Vaccine Distribution Program
November 19, 2009 13:27 ET
|
CyberShift
PARSIPPANY, NJ--(Marketwire - November 19, 2009) - CyberShift, a global provider of workforce
management and
expense management software and services, today announced that its
Workforce Management...
MIT Enterprise Forum of Cambridge Presents "Vaccines and Global Health: New Technologies Create Global Opportunities"
November 04, 2009 15:40 ET
|
MIT Enterprise Forum of Cambridge
CAMBRIDGE, MA--(Marketwire - November 4, 2009) - On November 9, the MIT Enterprise Forum of
Cambridge will present a session on the development of new technologies
for the research, development and...